Sign up for our weekly email for inspiring and informative stories from Israel
Donate
The top news and stories from Sheba Medial Center.
Fixed-dose OIT appeared safe and effective for younger children with high-threshold peanut allergy, according to a single-center, cross-sectional prospective study published in Annals of Allergy, Asthma & Immunology. Soad Haj […]
Read More
Israel’s Virusight uses the power of AI to deliver results at a fraction of the time and cost. A 20-second Covid test developed in Israel delivers results that are almost […]
The U.S. Centers for Disease Control and Prevention has stepped up its monkeypox guidance, urging people to take extra precautions as global cases of the virus surpass 1,000. The CDC […]
Pancreatic cells that produce insulin can be destroyed in overweight teens as well as adults, requiring injections of insulin, according to Sheba study. For many years, diabetologists have been saying […]
“The positive results from the first stage of this trial in such a heavily pre-treated relapsed or refractory acute myeloid leukaemia population is encouraging, especially with three of the patients […]
Images acquired with AI guidance software deemed usable in 100 percent of cardiac patient At the 69th Annual Conference of the Israel Heart Society, UltraSight, an Israeli-based digital health pioneer […]
MEDX Xelerator’s newly-established incubator branch in the Sakhnin Valley will help spur more startups in the health and medical sectors, and boost healthcare services and the economy. The MEDX Xelerator […]
Spontaneous conception of quadruplets is not common, estimated at only 1 pregnancy out every 700,000. Diana Almarbua, a 21-year-old Israeli gave birth to a quadruplet this week in Israel, marking […]
A novel artificial intelligence algorithm can detect inflammatory bowel disease in up to 38% of patients years before it would be diagnosed in the primary care setting. The software could […]
Biomica Ltd. (Biomica), an emerging biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), reported today that it signed a collaboration agreement with […]
